The bill H. R. 9616 aims to amend the Federal Food, Drug, and Cosmetic Act to allow quicker approval of drugs when new safety information is added to their labeling. It ensures that a drug won't be considered ineligible for approval if its labeling omits safety details that...
Simple Explanation
The bill wants to make it faster to approve new medicines by adding important safety information to their labels. It also makes sure these medicines have the right safety details on their labels, but doesn't change any special rights companies have over their medicine information.